Stock Alert

Overall view of all the recent market developments which will help in your investment decisions

HDFC, SBI, Cipla, DLF, Bank of Baroda in focus
01-Aug-22 08:28Hrs IST

Housing Development Finance Corporation (HDFC), State Bank of India (SBI): HDFC said that it has entered into a share purchase agreement (SPA) with SBI for acquiring of 97,500 equity shares of HDFC Venture Capital (HVCL). The corporation holds 80.50% of the paid-up equity share capital of HVCL, a subsidiary of the corporation. The SPA is for the acquisition of 97,500 equity shares of HVCL representing 19.50% of its paid-up share equity capital at a per share price of Rs 10, aggregating to a total consideration of Rs 9.75 lakh.

Cipla: Cipla's consolidated net profit slipped 4% to Rs 686.40 crore on 2.3% decline in total revenue from operations to Rs 5,375.19 crore in Q1 FY23 over Q1 FY22.

Dr. Reddy's Laboratories: Dr. Reddy's Laboratories said that it has entered into a licensing agreement with Slayback Pharma to obtain exclusive rights in the first-to-file ANDA for the private label version of Lumify in the U.S.

DLF: The realty major's consolidated net profit rose 39.9% to Rs 469.57 crore on a 26.5% increase in net sales to Rs 1,441.63 crore in Q1 FY23 over Q1 FY22.

Bank of Baroda: On standalone basis, Bank of Baroda's net profit surged 79.39% to Rs 2,168.13 crore on 1.02% rise in total income to Rs 20,119.52 crore in Q1 FY23 over Q1 FY22.

Torrent Pharmaceuticals: On consolidated basis, Torrent Pharmaceuticals' net profit rose 7% to Rs 354 crore on 10% increase in net revenue from operations to Rs 2,347 crore in Q1 FY23 over Q1 FY22.

Godrej Properties: Godrej Properties said that ICRA had upgraded the long-term (LT) rating on the debt instruments of the company and has revised the outlook on the same to 'stable'.

Yes Bank: Yes Bank on Friday (29 July 2022) announced raising equity capital of about $1.1 billion (~ Rs 8,900 crore) from funds affiliated with two global private equity investors - Carlyle and Advent International, with each investor potentially acquiring upto a 10% stake in Yes Bank. This will be raised through a combination of ~$640 million (~Rs 5,100 crore) in equity shares and ~$475 million (~Rs 3,800 crore) through equity share warrants.

Nazara Technologies: Nazara Technologies' consolidated net profit rose 22.2% to Rs 16.50 crore on 70% jump in net sales to Rs 223.10 crore in Q1 FY23 over Q1 FY22.

Suven Pharma: The US Food and Drug Administration (USFDA) completed a pre-approval inspection at Casper Pharma formulations manufacturing facility situated at GMR Hyderabad SEZ. Casper Pharma is a wholly-owned subsidiary of Suven Pharmaceuticals, Hyderabad, India. The inspection was conducted from 25 July through 29 July 2022.

CreditAccess Grameen: CreditAccess Grameen's consolidated net profit surged to Rs 139.56 crore in Q1 FY23 as against Rs 20.29 crore recorded in Q1 FY22. The microfinance lender's total income jumped 23.2% to Rs 760.52 crore in Q1 FY23 from Rs 617.37 crore reported in the corresponding quarter previous year.

Powered by Capital Market - Live News

Attention Investor :

"Prevent unauthorised transactions in your account ; Update your mobile numbers/email IDs with Us. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day” - Issued in the interest of Investors"

"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."

"No need to issue cheques by investors while subscribing to Equity IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

A Muthoot M George Enterprise